WSJ Pro Venture Capital: Wellington Management Raises US$476 Million for Second Biotech Venture Fund
Co-heads of biotech private investments I-hung Shih and Nilesh Kumar spoke with the Wall Street Journal to discuss the recent US$476M final close of Biomedical Innovation Fund II and how Wellington is a “one-stop shop” for the next generation of innovative biotech companies.
Source: WSJ Pro Venture Capital. Permission required for reproduction.
- About Us
- My Account
Explore our insights
Sustainable Investment Solutions
Media and Press